About Elevance Health Inc
- Industry: Health Care
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.elevancehealth.com/
Frequently Asked Questions
What is the 52-week range for ELV?
The 52-week high is $436.24 and the 52-week low is $274.84.
What is the P/E ratio for ELV?
The Price to Earnings (P/E) ratio is 16.89.
What is the dividend yield for ELV?
The indicated annual dividend yield is 1.24%.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 11.24%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 2.47%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.78.
Analyst Recommendation Trends
Wall Street analyst consensus for ELV over the last few months:
Latest ELV News
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
How Much Downside Is Left In CVS Health Stock?
CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.
Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins
Cambiar Opportunity Fund, managed by Cambiar Investors, published its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets experienced a significant rebound in Q2, with the S&P 500 rising 15.2% and the Russell 2000 up 21.5%. Growth stocks outperformed value, although value retained a year-to-date lead. The market’s rise was fueled […]
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
INDIANAPOLIS, October 01, 2026--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs.
Elevance cracks down on hospital billing for off-campus care
The insurer said it’s trying to restrict hospitals from charging higher rates for services at off-campus outpatient departments. Hospital groups say the reimbursement cuts could threaten access to care.
Elevance Health's Quarterly Earnings Preview: What You Need to Know
Elevance Health is scheduled to report its third-quarter results soon, and analysts expect a double-digit earnings decline.
What Are UNH Stock Investors Betting On?
UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.
UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not
UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.
3 U.S. Dividend Stocks Offering Defensive Income as Fed Rate Pressure Persists
With traders bracing for another possible 0.25% Fed hike in October, solid labor data and firm inflation keep pressure on anything seen as risky. Defensive dividend stocks suddenly feel less boring and more like a potential anchor for a jumpier market, especially for investors who care about steady income when policy stays tight. This article breaks down three large cap dividend payers exposed to these macro shocks and explores how the latest data may help or hurt each stock. The three...
What Should CVS Stock Investors Be Watching Now?
If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.
Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast
By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod
Did UnitedHealth Name The Fix Before Its Stock Ran?
UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.
Can UNH Stock Keep Growing Earnings While Its Sales Stall?
UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.
How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet
Centene's robust cash flow is helping cut debt, with a lower debt-to-capital ratio and added liquidity reshaping its balance sheet.
'Vance-Led Task Force Set to Remove 760,000 Allegedly Fraudulent Obamacare Enrollments' - WSJ Exclusive
https://www.wsj.com/politics/policy/vance-led-task-force-set-to-remove-760-000-allegedly-fraudulent-obamacare-enrollments-0fbb72d7
Tracking William Nygren's Harris Associates Portfolio - Q2 2026 Update
Harris Associates' 13F portfolio rose to $75.42B in Q2 2026, with 30 core positions exceeding 1.25% each. Read more on the portfolio here.
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed
Elevance Health has delivered a 1 year gain that puts the stock firmly on investors' radar, and the latest reaffirmed earnings outlook has only sharpened the focus on what you are paying for each dollar of profit. With the price around US$410.95 at the last close, the key issue now is whether that tag lines up with the insurer's earnings power. The stock is up 33.6% over the past year, which raises the question of whether that move is grounded in its underlying earnings profile. Management...
Dividend Champion, Contender, And Challenger Highlights: Week September 20
Track weekly dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend dates and pay dates here.
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?
CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.
2 Surging Stocks on Our Watchlist and 1 We Brush Off
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.
Baron Health Care Fund Q2 2026 Portfolio Activity
During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43.
ELV or DHR: Which Is the Better Value Stock Right Now?
ELV vs. DHR: Which Stock Is the Better Value Option?
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth
CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.
CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?
The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.
Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?
UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.
3 Profitable Stocks to Keep an Eye On
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.
Can Centene's Medicare Advantage Strategy Unlock Better Margins?
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.
Up 36% in the Last 12 Months, Does Elevance Health Stock Have More Room to Run Through 2028?
Key Takeaways:Guidance Raised: Elevance Health lifted 2026 adjusted EPS guidance to at least $27, up from prior levels, after a strong Q2. Price Projection: Based on current execution, ELV stock could reach $494 by December 2028.
Should You Buy Elevance Health Stock For The Margin It Lost?
Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.
Thursday's session: top gainers and losers in the S&P500 index
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.
What's going on in today's session: S&P500 movers
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.
Elevance Health Inc's Dividend Analysis
Elevance Health Inc (NYSE:ELV) recently announced a total dividend of $1.72 per share, with the ex-dividend date set for 2026-09-10. For investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the upcoming payment. As investors look forward to this next distribution, the spotlight also shines on the company's dividend history, yield, and growth rates.
Elevance Health Affirms FY2026 GAAP EPS expected to be more than $20.10 vs $20.26 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $20.10 vs $20.26 Est..
Elevance Health Affirms FY2026 Adj EPS expected to be more than $27.00 vs $26.91 Est
Elevance Health (NYSE:ELV) Affirms FY2026 expected to be more than $27.00 vs $26.91 Est..
Why Is UNH Stock Trading At A Premium With The Slowest Growth?
UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.
UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation
TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.
2 Reasons to Watch ELV and 1 to Stay Cautious
What a time it’s been for Elevance Health. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $414.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
Dividend Champion, Contender, And Challenger Highlights: Week September 6
Explore this weekâs dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates.
Elevance Health (ELV) Stock Still Looks Undervalued Despite Its 37% Run
After a strong 37.5% return over the past year, Elevance Health now trades with a high value score and an undervalued read on market multiples, which raises the question of whether the recent share price strength has fully reflected that signal or not. Elevance Health has delivered a 37.5% 1 year return, so any further upside now depends on how much fundamental value is still not priced in. The appointment of Dr. Patrick Fox to lead Carelon Behavioral Services, alongside greater use of AI in...
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-03 | Wessling Erin M | -255 | $414.78 | $105,769 |
| 2026-09-02 | Wessling Erin M | -94 | $405.84 | $38,149 |
| 2026-09-02 | Craig Ryan R | -144 | $405.84 | $58,441 |
| 2026-07-17 | BOUDREAUX GAIL | +2,045 | $368.25 | $753,071 |
| 2026-07-17 | BOUDREAUX GAIL | +680 | $366.41 | $249,159 |
| 2026-07-17 | PERU RAMIRO G | +1,000 | $366.05 | $366,050 |
| 2026-06-12 | Penczek Ronald W | -369 | $403.16 | $148,766 |
| 2026-06-11 | Dixon Robert L JR | -151 | $401.77 | $60,667 |
| 2026-05-19 | Penczek Ronald W | -877 | - | - |
| 2026-05-19 | Penczek Ronald W | -654 | - | - |
| 2026-05-19 | Penczek Ronald W | -1,531 | $403.13 | $617,192 |
| 2026-05-19 | Penczek Ronald W | +877 | $311.48 | $273,168 |
| 2026-05-19 | Penczek Ronald W | +654 | $271.27 | $177,411 |
| 2026-05-13 | Jallal Bahija | +563 | - | - |
| 2026-05-13 | Neri Antonio F | +563 | - | - |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | +563 | - | - |
| 2026-05-13 | DeVore Susan D. | +563 | - | - |
| 2026-05-13 | Dixon Robert L JR | +563 | - | - |
| 2026-05-13 | SCHULMAN AMY W | +563 | - | - |
| 2026-05-13 | PERU RAMIRO G | +563 | - | - |
| 2026-05-13 | COLLIS STEVEN H | +563 | - | - |
| 2026-05-13 | HAY LEWIS III | +563 | - | - |
| 2026-05-13 | Schneider Ryan M. | +563 | - | - |
| 2026-03-12 | SCHULMAN AMY W | -26 | $287.5 | $7,475 |
| 2026-03-06 | Kendrick Charles Morgan JR | -3,196 | $284.92 | $910,604 |
| 2026-03-05 | COLLIS STEVEN H | +3,000 | $289.84 | $869,520 |
| 2026-03-03 | Wessling Erin M | -417 | $284.03 | $118,441 |
| 2026-03-03 | Craig Ryan R | -309 | $284.03 | $87,765 |
| 2026-03-03 | Kendrick Charles Morgan JR | -467 | $284.03 | $132,642 |
| 2026-03-03 | Kaye Mark | -353 | $284.03 | $100,263 |
| 2026-03-03 | Norwood Felicia F | -496 | $284.03 | $140,879 |
| 2026-03-03 | LAVU RATNAKAR | -222 | $284.03 | $63,055 |
| 2026-03-03 | Penczek Ronald W | -37 | $284.03 | $10,509 |
| 2026-03-03 | Haytaian Peter D | -446 | $284.03 | $126,677 |
| 2026-03-03 | BOUDREAUX GAIL | -1,736 | $284.03 | $493,076 |
| 2026-03-02 | Wessling Erin M | +11,754 | - | - |
| 2026-03-02 | Wessling Erin M | +2,976 | - | - |
| 2026-03-02 | Craig Ryan R | +11,754 | - | - |
| 2026-03-02 | Craig Ryan R | +2,976 | - | - |
| 2026-03-02 | Craig Ryan R | -25 | $294.07 | $7,352 |
| 2026-03-02 | Kendrick Charles Morgan JR | +15,870 | - | - |
| 2026-03-02 | Kendrick Charles Morgan JR | +2,532 | - | - |
| 2026-03-02 | Kendrick Charles Morgan JR | +4,017 | - | - |
| 2026-03-02 | Kendrick Charles Morgan JR | -1,211 | $294.07 | $356,119 |
| 2026-03-02 | Kaye Mark | +25,188 | - | - |
| 2026-03-02 | Kaye Mark | +10,202 | - | - |
| 2026-03-02 | Kaye Mark | +6,377 | - | - |
| 2026-03-02 | Kaye Mark | -271 | $294.07 | $79,693 |
| 2026-03-02 | Norwood Felicia F | +23,512 | - | - |
| 2026-03-02 | Norwood Felicia F | +2,865 | - | - |
| 2026-03-02 | Norwood Felicia F | +5,951 | - | - |
| 2026-03-02 | Norwood Felicia F | -1,421 | $294.07 | $417,873 |
| 2026-03-02 | LAVU RATNAKAR | +20,152 | - | - |
| 2026-03-02 | LAVU RATNAKAR | +6,802 | - | - |
| 2026-03-02 | LAVU RATNAKAR | +5,101 | - | - |
| 2026-03-02 | LAVU RATNAKAR | -315 | $294.07 | $92,632 |
| 2026-03-02 | Penczek Ronald W | +1,677 | - | - |
| 2026-03-02 | Penczek Ronald W | +266 | - | - |
| 2026-03-02 | Penczek Ronald W | +1,701 | - | - |
| 2026-03-02 | Penczek Ronald W | +426 | - | - |
| 2026-03-02 | Penczek Ronald W | -131 | $294.07 | $38,523 |
| 2026-03-02 | Haytaian Peter D | +2,865 | - | - |
| 2026-03-02 | Haytaian Peter D | -1,201 | $294.07 | $353,178 |
| 2026-03-02 | BOUDREAUX GAIL | +63,818 | - | - |
| 2026-03-02 | BOUDREAUX GAIL | +10,527 | - | - |
| 2026-03-02 | BOUDREAUX GAIL | +16,153 | - | - |
| 2026-03-02 | BOUDREAUX GAIL | -6,713 | $294.07 | $1,974,092 |
| 2026-02-02 | Craig Ryan R | -279 | $341.83 | $95,371 |
| 2026-02-02 | SCHULMAN AMY W | +218 | - | - |